This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AMD Shares Ride on Strong EPYC Demand: Buy, Sell or Hold the Stock?
by Aniruddha Ganguly
AMD's EPYC and Instinct momentum drives cloud, AI and enterprise growth, but valuation concerns and NVIDIA rivalry weigh on the outlook.
Oracle's NetSuite Momentum: Can It Boost Cloud Growth to New Heights?
by Zacks Equity Research
ORCL's NetSuite ERP drives double-digit SaaS growth, boosting cloud revenue momentum and positioning the company for stronger long-term demand.
Oracle (ORCL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of Oracle (ORCL) for the quarter ended August 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Oracle Stock Before Q1 Earnings: Buy Now or Wait for Results?
by Vasundhara Sawalka
ORCL's cloud momentum and AI innovations show promise, but investors may wait for clearer visibility on partnership revenue synergies before buying the stock.
Ciena (CIEN) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Ciena (CIEN) delivered earnings and revenue surprises of +28.85% and +4.00%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus
by Abhinab Dasgupta
Even in a choppy market, Zacks' strategies are spotlighting winners like Oracle, Intellia, and Pharming Group, proving the value of a disciplined, research-driven approach.
Oracle (ORCL) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oracle (ORCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
by Zacks Equity Research
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum.
AMD's AI Journey Rides on Strong Partner Base: What's the Path Ahead?
by Aniruddha Ganguly
AMD's expanding partner base, strong EPYC demand, and new AI collaborations fuel growth despite stiff competition from NVIDIA and Broadcom.
Salesforce Before Q2 Earnings: Should You Buy, Sell or Hold the Stock?
by Anirudha Bhagat
CRM's Q2 performance is likely to reflect the benefits of the growing adoption of generative AI-enabled solutions and continued cloud migration.
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock.
Oracle (ORCL) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Oracle (ORCL) stood at $240.11, denoting a +1.82% move from the preceding trading day.
Oracle Cloud Expansion in Focus: A Key to Future Momentum?
by Zacks Equity Research
ORCL's cloud revenues surge, fueled by AI demand and multi-cloud expansion, with management eyeing 40% growth in fiscal 2026.
Oracle Corporation (ORCL) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Oracle (ORCL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Can Momentum in Cloud Data Market Drive Upside in SNOW Stock?
by Zacks Equity Research
Snowflake is set to gain from rising cloud analytics demand, with AI Data Cloud and Snowpark driving platform adoption and revenue growth.
The Zacks Analyst Blog Highlights Oracle and Alphabet
by Zacks Equity Research
Oracle and Alphabet face off in the AI cloud race, but Alphabet's diversified ecosystem, stronger growth, and better valuation give it the edge.
PEGA's Cloud Backlog Climbs: A Sign of Strong Revenue Visibility?
by Zacks Equity Research
Pegasystems' cloud backlog gains 30% to $1.32B in Q2 2025, boosting revenue visibility and underscoring strong demand for its AI-powered solutions.
Oracle vs. Alphabet: Which AI Cloud Stock Has Better Upside Potential?
by Vasundhara Sawalka
GOOGL's diverse ecosystem and better valuation edge out ORCL's focused approach. Track GOOGL for entry.
Intuit (INTU) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Intuit (INTU) delivered earnings and revenue surprises of +3.77% and +2.30%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Intel's Revival Ahead After SoftBank's $2 Billion Investment
by Shaun Pruitt
Intel's revival as a leading chipmaker has gained traction following Tuesday's announcement that SoftBank had taken a 2% stake in the company worth $2 billion.
Australia Launch & AMEX Deal: Will TOST's Recipe Fuel its Growth Engine?
by Zacks Equity Research
Toast projects 29% growth in 2025 as international expansion and a new AMEX partnership fuel momentum in restaurant tech.
Here's Why Oracle (ORCL) Fell More Than Broader Market
by Zacks Equity Research
Oracle (ORCL) reached $234.62 at the closing of the latest trading day, reflecting a -5.8% change compared to its last close.
Oracle Strengthens GenAI Push: Will Google Cloud Tie-Up Pay Off?
by Zacks Equity Research
ORCL deepens its GenAI push with Google Cloud, embedding Gemini into OCI and apps to drive enterprise adoption and growth.
Beat the Market the Zacks Way: CBRE, Acadian, Fastenal in Focus
by Abhinab Dasgupta
CBRE, Acadian, and Fastenal highlight Zacks' market-beating picks as portfolios outpace broader indexes with strong 2025 gains.
Oracle Unveils AI EHR to Accelerate Cloud Growth and Healthcare Reach
by Zacks Equity Research
ORCL debuts AI-powered EHR with voice-first navigation, aiming to reshape healthcare tech and boost cloud growth.